FDA issues warning against 'microdosing' chocolate bars that sent 6 to the hospital

2024-06-09 19:58:39+00:00 - Scroll down for original article

Click the button to request GPT analysis of the article, or scroll down to read the original article text

Original Article:

Source: Link

The FDA is investigating Diamond Shruumz-brand microdosing chocolate bars. Eight people fell ill after consuming the product, the agency said. The symptoms included vomiting, seizures, and central nervous system depression. Sign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Read preview Thanks for signing up! Access your favorite topics in a personalized feed while you're on the go. download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . You can opt-out at any time by visiting our Preferences page or by clicking "unsubscribe" at the bottom of the email. Advertisement Eight people in four states fell ill after consuming Diamond Shruumz-brand microdosing chocolate bars, the FDA said on Friday. Microdosing is the practice of regularly taking a dose of a drug — typically a psychedelic — that is small enough not to feel any effect. Some people believe microdosing can improve creativity and mental health. It's become trendy in Silicon Valley. And some CEOs say they've added microdosing to their morning routine. This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Have an account? Log in .